Literature DB >> 18483766

Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands.

Stefano Costanzi1, Irina G Tikhonova, T Kendall Harden, Kenneth A Jacobson.   

Abstract

Accurate in silico models for the quantitative prediction of the activity of G protein-coupled receptor (GPCR) ligands would greatly facilitate the process of drug discovery and development. Several methodologies have been developed based on the properties of the ligands, the direct study of the receptor-ligand interactions, or a combination of both approaches. Ligand-based three-dimensional quantitative structure-activity relationships (3D-QSAR) techniques, not requiring knowledge of the receptor structure, have been historically the first to be applied to the prediction of the activity of GPCR ligands. They are generally endowed with robustness and good ranking ability; however they are highly dependent on training sets. Structure-based techniques generally do not provide the level of accuracy necessary to yield meaningful rankings when applied to GPCR homology models. However, they are essentially independent from training sets and have a sufficient level of accuracy to allow an effective discrimination between binders and nonbinders, thus qualifying as viable lead discovery tools. The combination of ligand and structure-based methodologies in the form of receptor-based 3D-QSAR and ligand and structure-based consensus models results in robust and accurate quantitative predictions. The contribution of the structure-based component to these combined approaches is expected to become more substantial and effective in the future, as more sophisticated scoring functions are developed and more detailed structural information on GPCRs is gathered.

Mesh:

Substances:

Year:  2008        PMID: 18483766      PMCID: PMC2789990          DOI: 10.1007/s10822-008-9218-3

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  73 in total

1.  Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins.

Authors:  D Rognan; S L Lauemoller; A Holm; S Buus; V Tschinke
Journal:  J Med Chem       Date:  1999-11-04       Impact factor: 7.446

2.  Knowledge-based scoring function to predict protein-ligand interactions.

Authors:  H Gohlke; M Hendlich; G Klebe
Journal:  J Mol Biol       Date:  2000-01-14       Impact factor: 5.469

3.  Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.

Authors:  J M Rieger; M L Brown; G W Sullivan; J Linden; T L Macdonald
Journal:  J Med Chem       Date:  2001-02-15       Impact factor: 7.446

4.  CoMFA-based comparison of two models of binding site on adenosine A1 receptor.

Authors:  I Doytchinova
Journal:  J Comput Aided Mol Des       Date:  2001-01       Impact factor: 3.686

5.  A general and fast scoring function for protein-ligand interactions: a simplified potential approach.

Authors:  I Muegge; Y C Martin
Journal:  J Med Chem       Date:  1999-03-11       Impact factor: 7.446

6.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

7.  Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods.

Authors:  W Sippl
Journal:  J Comput Aided Mol Des       Date:  2000-08       Impact factor: 3.686

8.  Ranking ligand binding affinities with avidin: a molecular dynamics-based interaction energy study.

Authors:  J Wang; R Dixon; P A Kollman
Journal:  Proteins       Date:  1999-01-01

9.  Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

Authors:  A H Li; S Moro; N Forsyth; N Melman; X D Ji; K A Jacobson
Journal:  J Med Chem       Date:  1999-02-25       Impact factor: 7.446

10.  New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.

Authors:  José Brea; Jordi Rodrigo; Antonio Carrieri; Ferran Sanz; M Isabel Cadavid; María J Enguix; María Villazón; Guadalupe Mengod; Yolanda Caro; Christian F Masaguer; Enrique Raviña; Nuria B Centeno; Angelo Carotti; M Isabel Loza
Journal:  J Med Chem       Date:  2002-01-03       Impact factor: 7.446

View more
  11 in total

Review 1.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor.

Authors:  Santiago Vilar; Joel Karpiak; Stefano Costanzi
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

3.  Hybrid receptor structure/ligand-based docking and activity prediction in ICM: development and evaluation in D3R Grand Challenge 3.

Authors:  Polo C-H Lam; Ruben Abagyan; Maxim Totrov
Journal:  J Comput Aided Mol Des       Date:  2018-08-09       Impact factor: 3.686

4.  Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A(1), A (2A), A (2B), and A (3) receptor antagonists.

Authors:  Francesco Sirci; Laura Goracci; David Rodríguez; Jacqueline van Muijlwijk-Koezen; Hugo Gutiérrez-de-Terán; Raimund Mannhold
Journal:  J Comput Aided Mol Des       Date:  2012-10-12       Impact factor: 3.686

5.  L-type prostaglandin D synthase regulates the trafficking of the PGD2 DP1 receptor by interacting with the GTPase Rab4.

Authors:  Chantal Binda; Samuel Génier; Jade Degrandmaison; Samuel Picard; Louis Fréchette; Steve Jean; Eric Marsault; Jean-Luc Parent
Journal:  J Biol Chem       Date:  2019-10-01       Impact factor: 5.157

6.  Predicting the biological activities through QSAR analysis and docking-based scoring.

Authors:  Santiago Vilar; Stefano Costanzi
Journal:  Methods Mol Biol       Date:  2012

7.  Computational ligand-based rational design: Role of conformational sampling and force fields in model development.

Authors:  Jihyun Shim; Alexander D Mackerell
Journal:  Medchemcomm       Date:  2011-05       Impact factor: 3.597

8.  Structure-activity relationships and molecular modeling of 1,2,4-triazoles as adenosine receptor antagonists.

Authors:  Jens Carlsson; Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  ACS Med Chem Lett       Date:  2012-07-30       Impact factor: 4.345

9.  Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models.

Authors:  Guo Li; Kendra M Haney; Glen E Kellogg; Yan Zhang
Journal:  J Chem Inf Model       Date:  2009-01       Impact factor: 4.956

Review 10.  Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery.

Authors:  Valère Lounnas; Tina Ritschel; Jan Kelder; Ross McGuire; Robert P Bywater; Nicolas Foloppe
Journal:  Comput Struct Biotechnol J       Date:  2013-04-02       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.